Beaupre Darrin has filed 4 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 175000 shares of IDEAYA Biosciences, Inc. ($IDYA) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | IDEAYA Biosciences, Inc. | $IDYA | Beaupre Darrin | Chief Medical Officer | A | Stock Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 88,485,238 | 9999.99% | 0.20% |
| Feb. 27, 2025 | IDEAYA Biosciences, Inc. | $IDYA | Beaupre Darrin | Chief Medical Officer | A | Stock Option (right to buy) | 185000 | $0.00 | 185,000.0000 | 81,678,069 | 9999.99% | 0.23% |
| March 1, 2024 | IDEAYA Biosciences, Inc. | $IDYA | Beaupre Darrin | Chief Medical Officer | A | Stock Option (right to buy) | 160000 | $0.00 | 160,000.0000 | 57,519,929 | 9999.99% | 0.28% |
| Feb. 24, 2023 | IDEAYA Biosciences, Inc. | $IDYA | Beaupre Darrin | Chief Medical Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 41,444,696 | 9999.99% | 0.22% |